KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Inventory: 2020-2024

Historic Inventory for Moderna (MRNA) over the last 5 years, with Dec 2024 value amounting to $117.0 million.

  • Moderna's Inventory fell 19.42% to $332.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $332.0 million, marking a year-over-year decrease of 19.42%. This contributed to the annual value of $117.0 million for FY2024, which is 42.08% down from last year.
  • Latest data reveals that Moderna reported Inventory of $117.0 million as of FY2024, which was down 42.08% from $202.0 million recorded in FY2023.
  • In the past 5 years, Moderna's Inventory ranged from a high of $1.4 billion in FY2021 and a low of $47.0 million during FY2020.
  • For the 3-year period, Moderna's Inventory averaged around $422.7 million, with its median value being $202.0 million (2023).
  • In the last 5 years, Moderna's Inventory surged by 2,965.96% in 2021 and then crashed by 78.71% in 2023.
  • Over the past 5 years, Moderna's Inventory (Yearly) stood at $47.0 million in 2020, then surged by 2,965.96% to $1.4 billion in 2021, then plummeted by 34.14% to $949.0 million in 2022, then plummeted by 78.71% to $202.0 million in 2023, then tumbled by 42.08% to $117.0 million in 2024.